home / stock / ghdx / ghdx news


GHDX News and Press, Genomic Health Inc. From 05/07/19

Stock Information

Company Name: Genomic Health Inc.
Stock Symbol: GHDX
Market: NASDAQ

Menu

GHDX GHDX Quote GHDX Short GHDX News GHDX Articles GHDX Message Board
Get GHDX Alerts

News, Short Squeeze, Breakout and More Instantly...

GHDX - Genomic Health beats by $0.07, beats on revenue

Genomic Health (NASDAQ: GHDX ): Q1 GAAP EPS of $0.34 beats by $0.07 . More news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

GHDX - Genomic Health Reports First Quarter 2019 Financial Results and Recent Business Progress

REDWOOD CITY, Calif. , May 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended March 31, 2019 . "In the first quarter of 2019, we delivered more than 17 percent overall revenue grow...

GHDX - Fiera Capital SMID Cap Growth Strategy Q1 '19 Commentary

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

GHDX - Small Cap Growth Strategy Q1 '19 Commentary

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

GHDX - Genomic Health to Announce First Quarter 2019 Financial Results and Host Conference Call on Tuesday, May 7, 2019

REDWOOD CITY, Calif. , April 30, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 7 at 4:30 p.m. Eastern Time to discuss its first quarter 2019 financial results. The c...

GHDX - Bulletproof Investing Performance Update: Week 71

Safety First: NASCAR driver Johanna Long and her helmet (Credit: Gearheads ) Bulletproof Investing: Week 71 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers....

GHDX - New Long-term Outcomes Data Presented at St. Gallen International Breast Cancer Conference Reinforce TAILORx Treatment Paradigm and Standard of Care Use for Oncotype DX Breast Recurrence Score® Test

REDWOOD CITY, Calif. , March 25, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that new data presented at the 16th St. Gallen International Breast Cancer Conference  in Vienna reinforce the utility of the Oncotype DX Breast Recurrence Score ® ...

GHDX - New Long-Term Outcomes Data Reconfirm Value of Oncotype DX Breast Recurrence Score® Test to Target Chemotherapy

- Real-world evidence reinforces TAILORx treatment paradigm and standard of care use for Oncotype DX ®  test - Importance of tailoring chemotherapy use and differences between tests acknowledged by leading international breast cancer specialists GENEVA , March 25, 2019 ...

GHDX - How To Increase Return And Control Market Risk With Momentum Stocks

Momentum is a pervasive force in the stock market. In other words, stocks that are rising strongly tend to continue doing so more often than not. There is abundant statistical research showing that investors can obtain superior returns by investing in high-momentum stocks over the long term....

GHDX - Genomic Health (GHDX) Investor Presentation - Slideshow

The following slide deck was published by Genomic Health, Inc. in conjunction with this Read more ...

Previous 10 Next 10